Locally Advanced Pancreas Cancer

2

Review clinical trials related to Locally Advanced Pancreas Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

The purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.

Participants needed: 36
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Xerient PharmaUpdated: May 1, 2026Locations: 4
Eligibility criteria

Cytologic or biopsy confirmed adenocarcinoma of the pancreas [+26]

Prior radiotherapy to the upper abdomen with overlap of. the anticipated SBRT fi... [+25]

Status: Recruiting

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-related data (imaging, dosimetry, clinical) before, during, and after treatment with definitive-intent chemoradiotherapy for patients with locally advanced cervical and pancreatic cancer.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: Nov 12, 2025Locations: 1
Eligibility criteria

Cervical cancer [+4]

Any issue (medical, anatomic, other) that might preclude safe acquisition of bio...